Released : December 06, 2016 09:34 RNS Number : 0823R MaxCyte, Inc. 06 December 2016 MaxCyte, Inc. ("MaxCyte" or the "Company") Issue of Equity from exercise of Share Options Maryland, USA - 06 December 2016: MaxCyte (LSE: MXCT), announces the issue and allotment of 12,805 new
Released : October 21, 2016 07:43 RNS Number : 1438N MaxCyte, Inc. 21 October 2016 MaxCyte, Inc. ("MaxCyte" or the "Company") Driector/PDMR Sharedealing Maryland, USA - 21 October 2016: MaxCyte (LSE: MXCT), the revenue-generating developer of next generation cell-based medicines,
Released : September 28, 2016 18:00 RNS Number : 1371L MaxCyte, Inc. 28 September 2016 MaxCyte, Inc. ("MaxCyte" or the "Company") Grant of Options Gaithersburg, MD , 28 September 2016 - MaxCyte (LSE: MXCT) , an established and revenue generating US-based developer and supplier of cell
Released : September 27, 2016 07:00 RNS Number : 8786K MaxCyte, Inc. 27 September 2016 MaxCyte, Inc. ("MaxCyte" or the "Company") Financial Results for the Six Months ended 30 June 2016 Maryland, USA - 27 September - MaxCyte, Inc. (LSE: MXCT) , an established and revenue generating
